Presentation is loading. Please wait.

Presentation is loading. Please wait.

Dipeptidyl Peptidase-4 Inhibitors, Peripheral Arterial Disease, and Lower Extremity Amputation Risk in Diabetic Patients  Chun-Chin Chang, MD, Yung-Tai.

Similar presentations


Presentation on theme: "Dipeptidyl Peptidase-4 Inhibitors, Peripheral Arterial Disease, and Lower Extremity Amputation Risk in Diabetic Patients  Chun-Chin Chang, MD, Yung-Tai."— Presentation transcript:

1 Dipeptidyl Peptidase-4 Inhibitors, Peripheral Arterial Disease, and Lower Extremity Amputation Risk in Diabetic Patients  Chun-Chin Chang, MD, Yung-Tai Chen, MD, Chien-Yi Hsu, MD, Yu-Wen Su, MD, Chun-Chih Chiu, MD, Hsin-Bang Leu, MD, PhD, Po- Hsun Huang, MD, PhD, Jaw-Wen Chen, MD, PhD, Shing-Jong Lin, MD, PhD  The American Journal of Medicine  Volume 130, Issue 3, Pages (March 2017) DOI: /j.amjmed Copyright © 2016 Elsevier Inc. Terms and Conditions

2 Figure Flow diagram of study selection process. DPP-IV = dipeptidyl peptidase-4; T2DM = type 2 diabetes mellitus. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2016 Elsevier Inc. Terms and Conditions


Download ppt "Dipeptidyl Peptidase-4 Inhibitors, Peripheral Arterial Disease, and Lower Extremity Amputation Risk in Diabetic Patients  Chun-Chin Chang, MD, Yung-Tai."

Similar presentations


Ads by Google